Literature DB >> 28954387

MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B.

Ming Wang1, Liang Wang2, Mingyun Zhang3, Xingde Li3, Zhongcheng Zhu3, HaiYan Wang3.   

Abstract

BACKGROUND: Dysregulation of microRNA(miRNAs) expression was reported in human esophageal squamous cell carcinoma (ESCC). MiR-214 has been found to acts as a tumor suppressor in some tumors including ESCC. The objective of the study was to investigate the functional effect of miR-214 on the regulation of human ESCC progression.
METHODS: The expression levels of miR-214 in 57 paired human ESCC tissues and adjacent normal tissues were examined by qRT-PCR. The capacities of cell proliferation and invasion were determined after up-regulation or down-regulation of miR-214 by performing cell viability assay, colony formation assay and transwell assay. Dual luciferase assays, Western blot analysis and qRT-PCR assay were used to demonstrate the association between CDC25B and miR-214. Western blot analysis assessed relative CDC25B protein expression.
RESULTS: We observed that miR-214 expression exhibited a frequent down-regulation in ESCC tissues and cells, compared to adjacent normal tissues and cells, respectively. Furthermore, up-regulation of miR-214 significantly inhibited cell proliferation and colony formation and cell invasion capacities in Eca9706 and Eca109 cells. However, down-regulation of miR-214 exhibited an opposite effects. Dual luciferase assays showed that CDC25B was identified as a direct target of miR-214. Meanwhile, up-regulation of miR-214 decreased CDC25B expression, whereas, down-regulation of miR-214 increased the CDC25B expression in Eca9706 and Eca109 cells. Moreover, we demonstrated that miR-214 inhibited Eca9706 and Eca109 cells proliferation and invasion through CDC25B.
CONCLUSION: Our results indicate that miR-214 function as a tumor suppressor and may be potential therapeutic target for ESCC.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CDC25B; Cell proliferation; Esophageal squamous cell carcinoma; miR-214

Mesh:

Substances:

Year:  2017        PMID: 28954387     DOI: 10.1016/j.biopha.2017.09.048

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.

Authors:  Xiaofeng Chen; Jiangyuan Du; Rui Jiang; Ling Li
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.

Authors:  Yuan-Yuan Fang; Ming-Rong Tan; Jian Zhou; Li Liang; Xiao-Yun Liu; Kun Zhao; Er-Chen Bao
Journal:  Onco Targets Ther       Date:  2019-11-18       Impact factor: 4.147

3.  Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.

Authors:  Hongjuan Song; Yuan Liu; Xin Jin; Yang Liu; Yanling Yang; Lei Li; Xuan Wang; Guilin Li
Journal:  J Cell Mol Med       Date:  2019-07-05       Impact factor: 5.310

4.  LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis.

Authors:  Jinlin Jia; Hongle Li; Jie Chu; Jinxiu Sheng; Chang Wang; Zimo Jia; Weiwei Meng; Huiqing Yin; Junhu Wan; Fucheng He
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 5.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

6.  LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis.

Authors:  Hongle Li; Jinlin Jia; Lijun Yang; Jie Chu; Jinxiu Sheng; Chang Wang; Weiwei Meng; Zimo Jia; Huiqing Yin; Junhu Wan; Fucheng He
Journal:  Onco Targets Ther       Date:  2020-12-22       Impact factor: 4.147

7.  Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma.

Authors:  Zhimin Shen; Tianci Chai; Fei Luo; Zhun Liu; Hui Xu; Peipei Zhang; Mingqiang Kang; Sui Chen
Journal:  Onco Targets Ther       Date:  2020-05-26       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.